N-Methyl-N-ethyltryptamine (MET) is a psychedelic tryptamine. It is closely related to DMT and DET.[1][2] The Lysergamide counterpart of MET is ETH-LAD, an analogue of LSD first developed and characterized by Alexander Shulgin.

There is very little information on the human pharmacology or toxicity of MET. The freebase is believed to be active via vaporization at 15 mg.[3]

References

  1. ^ Schifano F, Orsolini L, Papanti D, Corkery J. NPS: Medical Consequences Associated with Their Intake. Curr Top Behav Neurosci. 2017;32:351-380. doi:10.1007/7854_2016_15 PMID 27272067
  2. ^ Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci. 2018;36:159-199. doi:10.1007/7854_2016_466 PMID 28224459
  3. ^ "That's okay, you're good" MET trip report - The Vaults of Erowid

External links